- VXRT -1.78%
Search results
- 0.7061Add to watchlist-0.0128 (-1.78%)At close: Fri. Jun 21, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open0.7311High0.7420Low0.6880
- Mkt Cap125.28MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.718952 Wk. Low0.520052 Wk. High1.5400
Top storiesWhile institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the mostYahoo Finance · 10 hours agoRelated stocks
Find the latest Vaxart, Inc. (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing.
4 days ago · VXRT | Complete Vaxart Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest Vaxart Inc (VXRT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Get the latest Vaxart, Inc. (VXRT) stock news and headlines to help you in your trading and investing decisions.
4 days ago · A high-level overview of Vaxart, Inc. (VXRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Discover real-time Vaxart, Inc Common Stock (VXRT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
View the latest Vaxart Inc. (VXRT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Get Vaxart Inc (VXRT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
View Vaxart, Inc. VXRT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Jun 14, 2024 · Vaxart Provides Business Update and Full Year 2022 Financial Results. Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development. Get a real-time Vaxart, Inc. (VXRT) stock price quote with breaking news, financials, statistics, charts and more.